Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic disease of the lungs which is characterized by heavy symptom burden, especially in the last year of life. Despite recently established anti-fibrotic treatment IPF prognosis is one of the worst among interstitial lung diseases. In this review available evidence regarding pharmacological and non-pharmacological management of the main IPF symptoms, dyspnea and cough, is presented.
Author supplied keywords
Cite
CITATION STYLE
Janowiak, P., Szymanowska-Narloch, A., & Siemińska, A. (2022, July 28). IPF Respiratory Symptoms Management — Current Evidence. Frontiers in Medicine. Frontiers Media S.A. https://doi.org/10.3389/fmed.2022.917973
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.